Volume 15, Number 7—July 2009
Letter
Immunoglobulin G in Ebola Outbreak Survivors, Gabon
Table
Patient no. | Outbreak location and year | Adjusted OD at 1:1,600 dilution |
|||
---|---|---|---|---|---|
Day 5 | Day 10 | Day 30 | 2007 | ||
1 | Mayibout 1996 | 0.05 | 1.50 | 2.52 | 1.41 |
2 | Mayibout 1996 | 0.44 | 0.58 | 1.14 | 0.30 |
3 | Mayibout 1996 | 0.22 | 1.90 | 3.17 | |
4 | Mayibout 1996 | 2.09 | |||
5 | Mayibout 1996 | 2.31 | 0.65 | ||
6 | Mayibout 1996 | 1.11 | 3.46 | ||
7 | Booué 1996 | 2.64 | 0.71 | ||
8 | Booué 1996 | 1.56 | 0.49 | ||
9 | Booué 1996 | 1.26 | 1.55 | 0.31 | |
10 | Mekambo 2001 | 2.60 | |||
11 | Mekambo 2001 | 1.90 | 1.46 | ||
12 | Mekambo 2001 | 2.05 | 0.84 | ||
13 | Mekambo 2001 | 0.80 | 2.13 | ||
14 | Mekambo 2001 | 1.84 | |||
15 | Mekambo 2001 | 0.71 | |||
16 | Mekambo 2001 | 2.77 | |||
17 | Mekambo 2001 | 0.10 | 3.50 | ||
18 | Mekambo 2001 | 0.46 | 1.33 | ||
19 | Mekambo 2001 | 0.03 | 2.50 | ||
20 | Mekambo 2001 | 2.90 | 0.99 |
*Blank cells indicate data are missing or testing was not performed. OD, optical density.
Page created: November 10, 2010
Page updated: November 10, 2010
Page reviewed: November 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.